ALLMedicine™ Contraception Center

Mar 28th, 2023 - Countries in the Arabian Gulf, especially Saudi Arabia, deserve special attention due to the scarcity of information researched and discussed on Maternal and Child Health (MCH). This report focuses on trends in women of reproductive age, children ...

Mar 28th, 2023 - This study aimed to assess the experience and satisfaction with contraceptives and use of Combined Oral Contraceptives (COC) by women and compare their perceptions with those of gynaecologists. This was a multicentre survey study conducted in Port...

Mar 26th, 2023 - Adolescents should have access to high quality and responsive sexual and reproductive health, however, it is unclear to what extent the national policy on health and development of adolescent is implemented by health care workers in Plateau State....

Mar 26th, 2023 - Despite the rapidly growing interest in nanoparticle-mediated controllable male contraception and recovery of male fertility, novel applications of nanoparticles in these processes are limited by a knowledge gap regarding their transport and distr...

Mar 25th, 2023 - Everyone who desires long-acting reversible contraception should have timely access to contraceptive implants and intrauterine devices. Obstetrician-gynecologists and other reproductive health care clinicians can best serve those who want to delay...

Mar 22nd, 2023 - This review aims to summarize and assess key studies investigating the relationship between hormonal contraception and breast cancer risk. Approximately two-thirds of breast cancers express the estrogen receptor, and long-term exposure to estrogen...

Jun 27th, 2022 - Sixty-five percent of women aged 15-49 in the U.S. currently use some form of contraception, and about 13% of women in that age group regularly take an oral contraceptive. The FDA first approved a contraceptive pill for females in 1960, and now wo...

Apr 12th, 2022 - To provide health care providers with the best evidence on cannabis use with respect to women's health. Areas of focus include general patterns of cannabis use as well as safety of use; care for women who use cannabis; stigma; screening, brief int...

Apr 12th, 2022 - Fournir aux fournisseurs de soins de santé les meilleures données probantes sur l'utilisation de cannabis et la santé des femmes. Les domaines d'intérêt sont : les profils généraux d'utilisation du cannabis ainsi que la sécurité de la consommation...

Jul 10th, 2021 - To provide guidance on culturally competent contraception counselling that is free of coercion and promotes shared decision-making and patient autonomy. Individuals of reproductive age who seek contraception or counselling for family planning. Con...

Mar 22nd, 2023 - This review aims to summarize and assess key studies investigating the relationship between hormonal contraception and breast cancer risk. Approximately two-thirds of breast cancers express the estrogen receptor, and long-term exposure to estrogen...

Mar 16th, 2023 - This is a prospective, phase IIb, open label, single arm, multicenter study. The study protocol consists of a screening phase lasting 4 to 8 weeks, a suppression phase estimated up to 20 weeks, a 52-week maintenance/efficacy phase, and a 24-week (...

Mar 14th, 2023 - There are 4 planned site visits in total: V1 (day0), V2 (day21), V3 (month 3), V4 (month 6) Healthy adults aged 18 years and above in Argentina will be informed by a procedure approved by the ethical review committee before consent is sought to be...

Mar 10th, 2023 - Group 1 will first follow the MedDiet pattern for six weeks and then follow the UCLP diet pattern for six weeks. Group 2 will also follow both diet patterns but in the opposite order. Week 0 will be the baseline, week 6 will be the interim point a...

Mar 8th, 2023 - Sickle cell disease (SCD) is the most common inherited blood disorder in the United States, affecting 100,000 primarily Black people. The disease is characterized by chronic pain and infection, and ultimately reduces life expectancy by 20 years co...

Mar 27th, 2023 - The FDA approved leniolisib (Joenja) on Friday as the first treatment indicated for activated phosphoinositide 3-kinase delta syndrome (APDS), a rare genetic disorder that causes progressive primary immunodeficiency. Leniolisib, an oral small mole...

Mar 22nd, 2023 - Current or recent use of progestin-only contraceptives was associated with a small increase in risk of breast cancer, similar to the risk associated with combined hormonal contraceptives, according to a nested case-control study and meta-analysis ...

Mar 22nd, 2023 - Researchers report that use of any levonorgestrel-releasing intrauterine system was associated with a significantly increased risk of ectopic pregnancy, compared with other hormonal contraceptives, in a study published in JAMA. Dr.

Mar 22nd, 2023 - This review aims to summarize and assess key studies investigating the relationship between hormonal contraception and breast cancer risk. Approximately two-thirds of breast cancers express the estrogen receptor, and long-term exposure to estrogen...

Mar 21st, 2023 - Inserting an intrauterine device (IUD) at 2 to 4 weeks postpartum matched the standard interval when it came to complete expulsions, a randomized trial found. At 6-month follow-up, 2% of patients in the early placement group had a complete expulsi...